G4 structures in active chromatin are found within hypomethylated CGIs. To explore any potential relationship between G4 Control of DNA methylation level is critical for gene regulation, and the factors that govern hypomethylation at CpG islands (CGIs) are still being uncovered. Here, we provide evidence that G-quadruplex (G4) DNA secondary structures are genomic features that influence methylation at CGIs. We show that the presence of G4 structure is tightly associated with CGI hypomethylation in the human genome. Surprisingly, we find that these G4 sites are enriched for DNA methyltransferase 1 (DNMT1) occupancy, which is consistent with our biophysical observations that DNMT1 exhibits higher binding affinity for G4s as compared to duplex, hemi-methylated, or single-stranded DNA. The biochemical assays also show that the G4 structure itself, rather than sequence, inhibits DNMT1 enzymatic activity. Based on these data, we propose that G4 formation sequesters DNMT1 thereby protecting certain CGIs from methylation and inhibiting local methylation.
M ethylation of cytosine at C-5 is a key DNA modification in development and disease 1, 2 . In mammals, cytosine methylation occurs predominantly at CpG dinucleotides and is installed and maintained by three DNA methyltransferase enzymes (DNMT1, DNMT3A and DNMT3B) that are essential for development [3] [4] [5] . CpGs occur less frequently than expected in the mammalian genome and show a bimodal distribution with respect to methylation 6, 7 . Sparsely distributed CpGs (~90%), found in genic and intergenic regions, tend to be highly methylated, while CpGs found in dense GC-rich (guanine-cytosine rich) regions, so-called CpG islands (CGIs), are largely depleted of methylation and are prevalent at the promoters of house-keeping and developmental genes 8,9 . Outside of embryonic development, gross methylation patterns are generally stable across different tissues 10, 11 . Nonetheless, during key cellular events, methylation can be dynamic at specific loci to modulate gene expression, such as de novo methylation of some promoter CGIs with intermediate CpG density during lineage commitment 12 .
General rules on maintenance of the default methylation state are being uncovered and several studies suggest that CGI hypomethylation is sequence-dependent [13] [14] [15] [16] [17] [18] . Furthermore, DNMTs are reported to be actively and continuously excluded from CpG-poor distal regulatory regions through competitive inhibition with DNA binding proteins, such as NRF1 and CTCF/REST, thus maintaining the hypomethylated state of regulatory regions 19, 20 . Lowly methylated regions also co-localize with DNase I hypersensitive sites (DHS) marking accessible chromatin regions 21 . The presence of enhancer chromatin marks, such as histone modifications, also play an important role in forming the unique chromatin structure of CGIs 22, 23 . In mouse embryonic stem cells, the CXXC finger protein 1, Cfp1, is believed to promote CGI hypomethylation through binding unmethylated CpG and recruitment of H3K4 methyltransferases to promote H3K4me3 24, 25 . However, Cfp1 binding and/or H3K4me3 are not required for the "protection" of CGI from DNA methylation since Cfp1 knockout results in a dramatic loss of H3K4me3 at CGIs without increasing DNA methylation 24 . This suggests that Cfp1 binding and/or H3K4me3 are not required to prevent CGIs from DNA methylation, and thus there may be other factors that are fundamental to impart the hypomethylated state.
Alternative DNA secondary structures, known as G-quadruplexes (G4s), are found within certain G-rich sequences and arise through the self-association of guanine bases to form stacked tetrads ( Fig. 1a) 26 . G4s are increasingly being recognized as important features in the genome and over 700,000 G4s have been biophysically mapped in purified human genomic DNA by high-throughput sequencing 27 . G4 structures have been observed in human using immunofluorescence with a G4-specific antibody (BG4) 28 and linked with transcriptional regulation, and they are enriched in gene promoters including many oncogenes 26, 29 . Recently, G4-chromatin immunoprecipitation sequencing (G4-ChIP-seq) has been developed to map G4 structures in human chromatin 30, 31 . Corroborating a link with transcription, the majority of G4-ChIP-seq sites were found predominantly in regulatory, nucleosome-depleted chromatin, particularly in gene promoters 31, 32 . As both G4s and hypomethylated CGIs are associated with actively transcribed genes 9, 31 , this raises the question of whether there is an interplay between G4 formation and DNA methylation.
Herein we present evidence that most G4 structures, as detected by G4-ChIP-seq, are formed in regions comprising unmethylated CGIs in the human genome. We also uncover a striking colocalization of G4 structures and DNMT1 docked at CGIs, and we demonstrate that DNMT1 methylation activity is inhibited by DNA G4 structures. Our data suggest a mechanism for the "protection" of CGIs from methylation by G-quadruplex structures that locally sequester and inhibit DNMT1. 
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structures in chromatin and methylation levels, we employed human K562 chronic myelogenous leukemia cells in which methylation has been comprehensively characterized at single base resolution using whole genome bisulfite sequencing (WGBS) by the ENCODE project 33 . We generated a genome-wide dataset for G4 structures by G4 ChIP-seq 31 using the G4-specific antibody BG4 28 and compared the BG4 peak overlap with CGIs 34 . Strikingly, we found that the majority of BG4 peaks (79%, 7,111/8,952) overlapped with a CGI (covering 23% of all CGIs) ( Fig. 1b ). The majority of CpG island regions span 200 to 1,000 base pair (bp) (median/mean, 569/775 bp), while BG4 peak regions span 100 to 400 bp (median/mean, 205/226 bp) ( Fig. 1c ). Then 83% (5,935/7,111) of these CGIs overlap with one BG4 peak ( Fig. 1d ). Furthermore, when the level of methylation at BG4 peaks was considered, we noted that there was a dramatic absence of methylation at BG4 peaks (mean 1%, median 0.5%), compared with average genome methylation (28.4%) ( Fig. 1e ). To rule out any effect of the cytosine methylation state on the ability of the BG4 antibody to recognize a G4 structure, an enzyme-linked immunosorbent assay (ELISA) was used to show that BG4 can bind to G4-structured DNA with equal affinity irrespective of the presence of cytosine methylation ( Supplementary Fig. 1 ). DNase I hypersensitive sites, which mark open chromatin, are also mainly hypomethylated (mean 11%, median 2.5%, Fig. 1e ). Confirming our previous observations 31 , the majority of BG4 peaks are found in open chromatin (DHSs, 97%, 8,655/8,952), and it is notable that these sites have the lowest methylation levels ( Fig. 1e ). Overall CGI methylation (mean 27%, median 8%, Fig. 1e ) shows a broader distribution than BG4 regions, since some CGIs are associated with active hypomethylated promoters while others are associated with inactive genes or gene bodies, and thus are more heavily methylated 9, 35 . This prominent association between BG4 peaks, hypomethylation, and particular CGIs is suggestive of a functional link between G4 secondary structures and the establishment and/or maintenance of low methylation status at these CGIs in active chromatin. It has recently been concluded from work in mouse embryonic stem cells that both high CpG density and high GC content are required to establish the hypomethylated state at CGIs 15 . It is therefore notable that BG4 peaks have a similar level of GC content to CGIs ( Fig. 1f ) with most (79%) being located in regions of CpG density comparable to that seen in CGIs ( Fig. 1g ). It has been suggested that CpG density alone is only a minor determinant of the unmethylated state, as dense CpG sequences embedded within an AT-rich (adenine-thymine rich) context are invariably highly methylated when inserted into the mouse genome 15, 16 . Indeed, when we compare the average methylation of CGIs ( Fig. 1h ) to that of BG4 peaks at different CpG dinucleotide densities, it is noteworthy that across a wide range of CpG densities the BG4 peak regions are always largely devoid of methylation ( Fig. 1h ). We also confirmed these observations using an alternative CGI definition set generated by CpGCluster algorithm 36 ( Supplementary Fig. 2a,b ). Furthermore, when methylation at CGIs is considered with respect to the presence or absence of a BG4 peak, it is notable that there is almost a total lack of methylation at CGIs with BG4 compared with those without ( Supplementary Fig. 2c ). This strongly suggests that CGIs associated with the physical presence of a G4 structure generally have particularly low methylation.
To explore low methylation in different CGI contexts, we calculated methylation levels relative to BG4 presence in CGIs containing (i) no promoter or DHS site, (ii) a promoter alone, (iii) a DHS site alone, and (iv) both a promoter and DHS site. It is apparent that CGIs containing a BG4 peak always have lower methylation in open (DHS+ ) or closed (DHS− ) chromatin, or in the presence or absence of a promoter ( Supplementary Fig. 2d ). CGIs with a DHS site and promoter but without a BG4 peak (4,500 sites) have higher methylation (mean 2%, median 2%) than those CGIs (5,567 sites) with a BG4 peak plus promoter and DHSs (mean 1%, median 0.5%) ( Supplementary Fig. 2d , right two panels). The lowest observed methylation states are found therefore at sites carrying a G4 structure, suggesting that the physical presence of a G4 structure within CGI is an important feature with respect to the hypomethylation state. This is illustrated in Fig. 1i which shows the coincidence of BG4 peaks with hypomethylated promoter CGIs for a representative genome region.
In earlier work, we found that treatment of human epidermal keratinocytes (HaCaT) cells with the HDAC (histone deacetylase) inhibitor entinostat led to increased BG4 binding signal primarily located in open chromatin promoter regions 37 . We therefore generated WGBS datasets to examine DNA methylation changes with respect to BG4 signal. Consistent with our observation in K562 cells, BG4 peaks in HaCaT cells have lower methylation compared with open chromatin and CGI regions ( Supplementary Fig. 2e ). In open-chromatin promoter CGI regions, 307 had a significant increase in BG4 signal (BG4 increase, > 1.5-fold change in signal and FDR (false discovery rate) < 0.05, see Methods). No change in BG4 signal was seen in 3,261 CGI promoter regions before and after treatment (BG4 constant), or for 1,504 G-rich CGI promoter regions that do not have a BG4 peak (BG4 negative) but have the potential to form a G4 in vitro 27 . Despite open-chromatin promoter CGI regions already being predisposed to low methylation, we see a statistically significant additional drop in methylation levels at CGIs where BG4 peak size increases after HDAC inhibition ( Supplementary Fig. 2f ). Overall, these data support the idea that formation of G-quadruplex structures in CGIs is linked to lower methylation.
DNMT1 is sequestered at G4 structures associated with low methylation.
Given that regions where G4 structures marked by BG4 peaks are generally observed to be hypomethylated, we considered that the DNA methyltransferases might have some form of physical interaction with G4 structures in the chromatin context. We focused on DNMT1 since DNMT1 knockout is lethal, causing global DNA methylation loss in all dividing somatic cells and human embryonic stem cells (ESCs) 3, 5, 38, 39 , whereas DNMT3A/B knockouts mainly affect non-CpG methylation in human ESCs 5 . When we considered the distribution of DNMT1 binding sites in K562 cells, downloaded from ENCODE 33 (516,483 peaks in total across both biological replicates), we found that 52% (4,611/8,952, Monte Carlo simulation's P value 1.25× 10 4 ) of the G4 structures mapped by G4-ChIP (BG4 peaks) overlapped with at least one DNMT1 binding site. Of the remaining 4,341 BG4 peaks, 4,003 were within 1 kilobase (kb) of a DNMT1 binding site. The proximity of BG4 peaks to DNMT1 recruitment sites is illustrated graphically in Fig. 2a for a representative genome region. Intriguingly, when the distribution of DNMT1 binding is plotted relative to high, intermediate, or low methylated CGIs, we observe a prominent enrichment of DNMT1 binding at lowly methylated CGIs, which overlaps with those regions with the highest BG4 peak density as well as DHS sites (Fig. 2b) . A similar profile is also seen using an alternative CGI definition set generated by CpGCluster 36 (Supplementary Fig. 3 ). The observation that DNMT1 enrichment at G4 regions that lack methylation is, at first glance, somewhat unexpected and counter-intuitive, given that DNMT1 installs methylation. We therefore considered the possibility of a mechanism whereby DNMT1 protein is sequestered at these sites in active chromatin but prevented from methylating CpGs in that locality.
DNMT1 selectively binds to and is inhibited by G4 structures.
To address whether DNMT1 binds G4 structures directly, we carried out biophysical measurements using an ELISA to measure the binding of recombinant human FLAG-tagged full-length DNMT1 protein to immobilized target DNA structures (see Methods). Biotinylated single-stranded oligonucleotides of a sequence based Articles NATure STruCTurAl & MoleCulAr BIoloGy on the promoters of BCL2, KIT2, and MYC were chosen as these fold into well-characterized G4 structures [40] [41] [42] . Mutated versions (BCL2-mut, KIT2-mut, and MYC-mut) that are unable to form a G4 structure were also used as controls. The presence or absence of G4 folded structure with G4 oligonucleotides and mutated controls was confirmed by circular dichroism spectroscopy and ultraviolet thermal melting spectroscopic analysis ( Supplementary Fig. 4a-f ). We found that DNMT1 binds to all three G4 structures with low nanomolar affinity (dissociation constant K d [BCL2] = 9.6 ± 0.3 nM;
. DNMT1 showed a lower binding affinity for unmethylated duplex DNA (BCL2, 107 ± 5 nM; Fig. 3d ) and there was no specific binding observed for the single-stranded mutated oligonucleotide controls. Notably, DNMT1 generally showed a greater affinity for G4 structures than known DNMT1 substrates such as a hemi-methylated duplex DNA (BCL2, 85 ± 7 nM, Fig. 3e ), or a synthetic (dI-dC) 50 (deoxyinosine-deoxycytosine) substrate (75 ± 2 nM, Fig. 3f ). DNMT1 binding to G4 structures does not appear to depend on CpG dinucleotides, since the absence of CpG in the MYC G4 did not preclude DNMT1 binding (Fig. 3c) . To begin to dissect the binding mode of DNMT1 to G4s, we used a competition ELISA assay. 50 nM immobilized BCL2 G4 (K d for DNMT1 = 9.6 nM, Fig. 3a ) was incubated with DNMT1 protein in the presence of increasing concentrations of competitors. Even with 100-fold excess (5 μ M) of DNA duplex (K d for DNMT1 = 107 nM, Fig. 3d ) or poly(dI-dC) (K d for DNMT1 = 75 nM, Fig. 3f ), there was no inhibition (Fig. 3g ). This suggests that G4s and duplex DNA occupy different binding sites and that the catalytic domain is not involved in G4 binding. A similar, non-overlapping G4 and duplex binding has also been observed in other proteins such as TRF2 43 and Rap1 44 .
The relatively high binding affinity and selectivity of DNMT1 for DNA G4 structures is consistent with the observation that DNMT1 shows some localization to G4 structures in K562 cells ( Fig. 2a,b) . To validate the association with low methylation in the locality G4 sites in the genome, we evaluated whether G4 DNA could actually inhibit DNA methylation on a standard assay using poly(dI-dC) as the substrate 45 of DNMT1 using a fluorometric biochemical assay (Abcam, see Methods). Specifically, we evaluated different concentrations of folded G4-structured oligonucleotides or mutated non-G4 controls, where the presence or absence of G4 structure had been confirmed by circular dichroism spectroscopy ( Supplementary Fig.  4g -i). We indeed found that each of three G4 structures resulted in significant inhibition of DNMT1 methyltransferase activity whereas the mutated control oligonucleotides did not ( Fig. 3h-j) . Gratifyingly, the potency of inhibition by each G4 was related to the binding affinity for DNMT1, as determined by ELISA with BCL2 being the most potent inhibitor (50% inhibition at ~25 nM), MYC being least potent (50% inhibition at ~1 μ M), and KIT2 being intermediate (50% inhibition at ~90 nM). No inhibition of activity was seen with mutated controls ranging from 400 nM to 8 μ M Rep1 Rep2 
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concentration. C-rich oligonucleotides complementary to the G4 sequences (BCL2-CCC, KIT2-CCC, and MYC-CCC) or corresponding duplex DNA also had no effect on DNMT1 activity ( Supplementary Fig. 4j-l) . We also tested G4 oligonucleotides that were able to fold into a G4 structure but carried a reduced number CpGs (BCL2, KIT) or had a number of artificially introduced CpGs (MYC). In all cases, changes in the number of CpG sites only had minor effects on DNMT1 inhibition ( Supplementary Fig. 4j-l) . Taken together, these results indicate a novel and unexpected feature of G4 structures as potential genomic regions that promote the unmethylated state through recruitment and inhibition of DNMT1 activity.
Recruitment of DNMT to G4 structures shapes the methylome.
The above data suggest that there is a striking lack of methylation (Fig. 1e,h and Supplementary Fig. 2a-d ) in chromatin regions where G4 structure formation is observed. To rigorously question whether this observation was related to the detectable formation of a G4 structure in chromatin (that is, a BG4 peak), or merely the G-rich sequences per se with potential to form a G4 structure, the methylation profile for BG4 peak regions was compared with those of G-rich sequences that can physically form a G4 structure in an in vitro sequencing assay 27 (here called sequences with the potential to form G4s, Fig. 4a ). As the majority of BG4 peaks (8,210) are Fig. 3 | DNMT1 selectively binds and is inhibited by G4 structures. a-f , ELISA assays testing the binding of recombinant DNMT1 to G4 structure and control oligonucleotides. Binding curves for: a, BCL2 G4 and non-G4-forming control (BCL2-mut); b, KIT2 G4 and non-G4-forming control (KIT2-mut); c, MYC G4 and non-G4-forming control (MYC-mut); d, BCL2 duplex DNA; e, BCL2 hemi-methylated duplex DNA; f, (dI-dC) 50 . Absorbance was measured at 450 nm. a.u., arbitrary unit. Sequences of oligonucleotides are given below the graphs. g, Binding curve of BCL2 G4 in the presence of different concentrations of BCL2 duplex or poly(dI-dC). h-j, Relative methylation activity of recombinant DNMT1 in the presence of G4 structure and control oligonucleotides: h, BCL2 G4 and BCL2-mut; i, KIT2 G4 and KIT2-mut; j, MYC G4 and MYC-mut. Shown are mean± s.d., n = 3 independent experiments in all plots but g (n = 2). Source data for the graphs are available online.
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found in open chromatin, only sequences with potential to form G4s located in open chromatin (36,015) were considered. The mean and median lengths are 226/205 bp for BG4 peaks, and 383/285 bp for the latter. G-rich sequences with the potential to form a G4 are largely hypomethylated (12%), with methylation levels rising in the flanking regions (45%), whereas BG4 peaks have substantially lower methylation (down to 1%) with the flanking regions being more methylated (60%). The contrast between lowest methylation at BG4 sites with highest methylation at distal flanking regions is also exemplified in the genome browser view in Fig. 1i . While sequences with potential to form a G4 but without a BG4 peak correlate with the lack of methylation, there is a further dramatic loss of methylation due to the physical presence of a G4 structure (i.e., carrying a BG4 peak), with these regions also being marked by a greater methylation flanking the G4 structure. Regions with a G4 structure also correspond to CGIs that mark particular active genes, and this is in keeping with our previous data showing that G4s are associated with particular chromatin states to promote elevated transcription 31 . R-loops (three-stranded DNA-RNA hybrids) have also been linked to reduced methylation in transcribed CpG island promoters 46, 47 . As R-loops form in a similar genomic context to G4s, we tested the correlation of R-loops, BG4 peaks, and methylation. Using the K562 R-loop dataset 46 , we found that 5,685 BG4 peaks overlap with an R-loop while 3,267 BG4 peaks do not, and that BG4 peaks are depleted of methylation independent of R-loop presence ( Supplementary Fig. 5 ). This suggests that G4 structure is strongly linked to hypomethylation, irrespective of the presence of an R-loop.
Discussion
Here we have provided evidence for a link between DNA secondary structure formation and epigenetic status. We have uncovered a unique chromatin context whereby certain CGIs in active chroma-tin are depleted in methylation but carry a G4 structure, and also the surrounding flanking regions display higher than average methylation. This suggests that G4s may impart a previously unknown and important function in the establishment of epigenome. We propose a model (Fig. 4b) in which G4 formation, together with transcription factor binding 19, 20 , contributes to loss of methylation at key genomic loci by sequestering DNMT1, via G4 recognition, and locally inhibiting DNMT1 function at CpG islands. It is noteworthy that this mechanism resembles a recently proposed model for recruitment and inhibition of PRC2 complex by a RNA G-quadruplex present in the HOTAIR lncRNA 48, 49 . This suggests that there may be other mechanisms for epigenetic regulation that operate by the sequestration and inhibition of epigenetic modifiers mediated by high-affinity interactions with nucleic acid secondary structures.
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Methods Cell culture. Mycoplasma-free human chronic myelogenous leukemia K562 cells (CCL-243) were purchased from ATCC and grown in RPMI1640 (Glutamine plus, Life Technologies) supplemented with 10% of fetal bovine serum and 100 U ml -1 penicillin-streptomycin (Life Technologies). All cell stocks were regularly tested for mycoplasma contamination.
G-quadruplex ChIP-seq. ChIP-seq for G-quadruplex structures (G4-ChIP-seq) was performed using the G4-specific antibody BG4 essentially as described previously 31 .
Oligonucleotide annealing. All oligonucleotides were PAGE purification quality (Sigma). For G4 formation, 10 µ M DNA oligonucleotide was annealed in 10 mM Tris HCl, pH 7.4, 100 mM KCl by heating at 95 °C for 5 min followed by gradually cooling to 21 °C. For double-stranded DNA, 10 µ M forward and reverse strand oligonucleotides were mixed and annealed in 10 mM Tris HCl, pH 7.4, 100 mM NaCl in the same manner. 20 µ M (dI-dC) 50 was annealed as for double-stranded DNA.
Enzyme-linked immunosorbent assay. ELISAs for binding affinity and specificity were performed as described previously 28 In vitro DNA methylation assay. DNA methylation assays were performed using a DNMT Activity Assay Kit (Fluorometric, ab113468, Abcam) as per manufacturer's instructions. Briefly, 100 ng of recombinant DNMT1 was incubated with substrate assay wells in the presence of different concentrations of G4 or non-G4 oligonucleotides at 37 °C for 90 min. Methylation levels were quantified from the binding of an anti-5-methylcytosine antibody detected by fluorescent secondary antibody. The fluorescence signal was measured using a PHERAstar microplate reader (530 nm excitation, 590 nm emission). DNMT enzyme activity is proportional to the fluorescence intensity (relative fluorescence unit, RFU) measured. Relative methylation activity is then calculated against mock control.
Circular dichroism spectroscopy. Circular dichroism spectra were recorded on an Applied Photo-physics Chirascan circular dichroism spectropolarimeter using a 1 mm path length quartz cuvette. Circular dichroism measurements were performed at 298 K over a range of 220-300 nm using a response time of 0.5 s, 1 nm pitch, and 0.5 nm bandwidth. The recorded spectra represent a smoothed average of three scans, zero-corrected at 300 nm (molar ellipticity θ is quoted in 105 o cm 2 dmol −1 ). The absorbance of the buffer was subtracted from the recorded spectra. Oligonucleotides were dissolved in lithium cacodylate buffer (100 mM, pH 7.2) containing 100 mM of KCl and 1 mM of EDTA to the concentration of 10 μ M. Then 200 μ l of the oligonucleotides were annealed prior to measurement by warming up to 90 °C and slowly cooling down at room temperature.
Ultraviolet melting. For ultraviolet melting experiments, absorbance measurements at 295 nm were collected using a Varian Cary 100-Bio ultraviolet− visible spectrophotometer. Samples (200 μ l) with a final concentration of 2 μ M were measured in black, small window, 1 cm path-length quartz cuvettes, covered with a layer of mineral oil (50 μ l). Samples were equilibrated at 5 °C for 10 min, heated to 95 °C, and cooled back to 5 °C at a rate of 0.5 °C min -1 . The samples were held for a further 10 min and then the 5 °C to 95 °C ramp was repeated. Data were recorded every 1 °C during both the melting and cooling steps. Then 200 μ l of oligonucleotides were annealed prior to measurement by warming up to 90 °C and slowly cooling down at room temperature.
Bioinformatics software and scripts. Bioinformatic data analyses and processing were performed using Perl, Bash, Python, and R programming languages. The following tools were also used: cutadapt ( G4-ChIP-seq analysis. Raw fastq reads from G4-ChIP-seq in K562 cells were trimmed with cutadapt 50 to remove adapter sequences and low-quality reads (mapping quality < 10). Reads were aligned to the human genome (version hg19)
with BWA 51 and duplicates were removed using Picard. Peaks were called by MACS2 52 (P < 10 −5 ) following our previous work 30, 31 : https://github.com/sblabbioinformatics/dna-secondary-struct-chrom-lands/blob/master/Methods.md Peaks were merged from different replicates with bedtools multiIntersect. Only peaks overlapping in three out five replicates were considered high confidence. K562 datasets for DHSs (ENCSR000EPC), DNMT1 ChIP-seq (ENCSR987PBI), and whole genome bisulfite sequencing (ENCSR765JPC) were downloaded from ENCODE. Promoters were defined as 1 kb (+ /− ) from the transcription start sites of 31,239 hg19 transcripts. Methylation levels at CpG sites with less than 5× coverage were discarded. If not otherwise specified, CGIs 34 were downloaded using the University of California Santa Cruz ( UCSC) table browser and then ported to human genome release hg38 using the batch coordinate conversion (liftover) tool of the UCSC. The alternative CGI sets were generated using CpGCluster 36 .
Enrichment analysis. ENCODE DHS and ChIP-seq datasets were normalized to a sequencing depth of 1 (that is, Reads Per Genomic Content, RPGC). Sequencing depth is defined as: (total number of mapped reads × fragment length)/effective genome size. The effective genome size was set to be 3,209,286,105 and enrichment values for DHSs and BG4 peaks over CGIs and their flanking sequences were visualized in R using the ggplot2 library. Enrichment values for DNMT1 over CGIs and their flanks were visualized with deepTools 53 .
Monte Carlo simulation. Monte Carlo simulation was used to calculate the significance of overlap between BG4 peaks and high-confidence DNMT1 peaks, defined by irreproducible discovery rate (IDR) in ENCODE's ChIP pipeline. We first counted how many BG4 peaks overlapped with sequences with the potential to form G4s in open chromatin. Such sequences were defined previously (ref. 27 ) as those causing polymerase stalling in potassium and/or pyridostatin conditions (749,339 sequences), and overlap with at least one DHS region (43,506 sequences). We then randomly selected the same number of sequences with potential to form G4s from all those present in open chromatin and counted how many overlapped with at least one high-confidence DNMT1 peak. The Monte Carlo P value was then calculated as (N + 1)/(M + 1), where M is the number of iterations and N is the number of times the same or more overlaps were observed between randomized sequences with potential to form G4s and high-confidence DNMT1 peaks (compared to the number of overlaps observed between BG4 peaks and high-confidence DNMT1 peaks). Randomization was repeated 8,000 times and on average the number of overlaps between the shuffled sequences with potential to form G4s and DNMT1 were 2-fold less than those observed between the BG4 and DNMT1 peaks. 
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Data collection
No software was used.
Data analysis
ELISA data were processed with Prism 7 (GraphPad Software Inc.). Bioinformatic data analyses and processing were performed using in-house Perl, Bash and R scripts and the following tools: cutadapt (1.15), BWA (0.7.15), Picard (2.8.3), (http://broadinstitute.github.io/picard), MACS (2.1.1), Bedtools (2.26.0), (http:// bedtools.readthedocs.io/en/latest/content/overview.html), Deeptools (2.5.1) and Bismark (v0.19.0). The pipeline used to analyze BG4 ChIP data is available at the following web page https://github.com/sblab-bioinformatics/dnasecondary-struct-chrom-lands/blob/master/Methods.md For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
